scispace - formally typeset
J

Joseph Benzakoun

Researcher at Paris Descartes University

Publications -  46
Citations -  934

Joseph Benzakoun is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 9, co-authored 23 publications receiving 547 citations. Previous affiliations of Joseph Benzakoun include French Institute of Health and Medical Research & École Centrale Paris.

Papers
More filters
Journal ArticleDOI

Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study.

TL;DR: Patients with severe COVID-19 and without ischemic infarcts had a wide range of neurologic manifestations that were be associated with abnormal brain MRIs, and eight distinctive neuroradiological patterns were described.
Journal ArticleDOI

Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.

TL;DR: COVID-19 patients may develop a wide range of neurological symptoms, which can be associated with severe and fatal complications, such as ischemic stroke or encephalitis, and the pathophysiology seems to involve an immune and/or inflammatory process given the presence of signs of inflammation in both cerebrospinal fluid and neuroimaging.
Journal ArticleDOI

Circumferential Thick Enhancement at Vessel Wall MRI Has High Specificity for Intracranial Aneurysm Instability.

TL;DR: In patients with intracranial aneurysm, a thick (>1 mm) circumferential pattern of wall enhancement demonstrated the highest specificity for differentiating between stable and unstableAneurysms.
Journal ArticleDOI

Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic Stroke.

TL;DR: Although MRI scan duration is slightly longer than CT, MRI- based selection for acute ischemic stroke patients is accomplished within a timeframe similar to CT-based selection, without delaying treatment or impacting functional outcome.
Journal ArticleDOI

White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy

TL;DR: In patients with AIS due to LVO and high burden of WMH as assessed by pretreatment MRI, the safety and efficacy profiles of MT are similar to those in patients with lower WMH burden and confirms that they are at higher risk of unfavorable outcome.